HealthcareServices

Cardiac Tissue Engineering Market Forecast 2025–2034: Where Businesses Should Invest Next

November 27, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Cardiac Tissue Engineering Market Between 2025 And 2029?

The cardiac tissue engineering market has witnessed significant growth in recent years. This market is expected to expand from $0.67 billion in 2024 to $0.8 billion in 2025, achieving a compound annual growth rate (CAGR) of 19.4%. The expansion observed historically can be attributed to various factors such as organ donor shortages, the increasing prevalence of cardiovascular diseases, innovations in biomaterials, rising investment in regenerative medicine, demand for personalized medicine, advancements in bioreactor systems, increasing government funding for biomedical research, and a growing focus on minimally invasive therapies.

The cardiac tissue engineering market is poised for significant expansion in the coming years. This market is projected to reach $1.62 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 19.2%. Contributing factors to this growth during the projection period include a heightened demand for customized cardiac treatments, an intensified emphasis on biologically engineered heart tissues, the broadening scope of regenerative medicine applications, increased partnerships between biotechnology companies and academic institutions, greater financial commitment to preclinical evaluation systems, and the increasing incidence of long-term heart conditions. Key developments expected in this period encompass the incorporation of artificial intelligence into tissue engineering, breakthroughs in scaffolds utilizing nanotechnology, the creation of dissolvable hydrogels, improved accuracy in 3D bioprinting, the application of bioreactors for optimal tissue development, and gene modification techniques to improve cardiac cells.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21129&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Cardiac Tissue Engineering Industry?

The escalating prevalence of cardiovascular diseases is anticipated to propel the expansion of the cardiac tissue engineering market in the foreseeable future. Cardiac tissue engineering is an interdisciplinary field dedicated to creating biological or bioartificial constructs aimed at repairing, regenerating, or replacing damaged heart tissue. The increasing occurrence of cardiovascular diseases primarily stems from unhealthy lifestyle choices, including poor diet, physical inactivity, smoking, and rising rates of obesity and diabetes. This approach addresses cardiovascular diseases by developing biomaterials, cell-based therapies, and bioengineered tissues to repair or regenerate compromised heart muscle and restore cardiac function. For instance, data from May 2023, reported by the Centers for Disease Control and Prevention, a US-based governmental organization, revealed a marginal increase in the percentage of coronary heart disease among female adults aged 18 and over, rising to 3.7% in 2023 from 3.6% in 2022. Consequently, the growing incidence of cardiovascular diseases is a key factor driving the growth of the cardiac tissue engineering market.

What Are The Major Segment Types Covered In The Cardiac Tissue Engineering Market?

The cardiac tissue engineeringmarket covered in this report is segmented –

1) By Product: Heart Valves, Vascular Grafts

2) By Material: Stem Cells, Scaffolds

3) By Application: Myocardial Infarction, Heart Valve Repair Or Replacement, Congenital Heart Disease Treatment, Other Applications

4) By End Users: Hospitals And Clinics, Academic And Research Institutes, Other End Users

Subsegments:

1) By Heart Valves: Bioprosthetic Heart Valves; Mechanical Heart Valves; Tissue-Engineered Heart Valves

2) By Vascular Grafts: Synthetic Vascular Grafts; Biologic Vascular Grafts; Tissue-Engineered Vascular Grafts

Which Ongoing Trends Are Expected To Shape The Cardiac Tissue Engineering Market Outlook?

Major companies operating in the cardiac tissue engineering market are focusing on developing technological advancements, such as 3D-engineered muscle tissues, to enhance the accuracy and efficiency of drug discovery for effective treatments of cardiovascular diseases. 3D-engineered muscle tissues are bioengineered constructs that replicate the structural and functional properties of human muscle, typically used for drug testing and disease modeling. For instance, in July 2022, Curi Bio Inc., a US-based biotechnology company, launched the Mantarray platform for human-relevant 3D heart and skeletal engineered muscle tissue (EMT) contractility analysis. The platform uses advanced tissue culture techniques to create highly functional muscle tissues that replicate the mechanical properties and behavior of natural muscle, offering a more accurate model for testing drugs. This technology is designed to enhance the development of therapeutic solutions by allowing researchers to study muscle contraction, response to stimuli, and disease modeling at a cellular level.

Which Global Market Leaders Are Shaping The Future Of The Cardiac Tissue Engineering Sector?

Major companies operating in the cardiac tissue engineering market are Biotronik SE & Co. KG, Terumo Corporation, Artivion Inc., Tissue Regenix Group plc, PromoCell GmbH, Xeltis AG, Carmat S.A., Bioheart Inc., Prellis Biologics Inc., Cytograft Tissue Engineering Inc., Avery Therapeutics Inc., Vascudyne Inc., Auto Tissue Berlin GmbH, CorMatrix Cardiovascular Inc., Humacyte Inc., BioCardia Inc., Osiris Therapeutics Inc., StemCells Inc., ViroMed Co. Ltd., Cardio3 Biosciences

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cardiac-tissue-engineering-global-market-report

What Are The Key Regional Factors Influencing The Cardiac Tissue Engineering Market Growth?

North America was the largest region in the cardiac tissue engineering market in 2024. The regions covered in the cardiac tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cardiac Tissue Engineering Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21129&type=smp

Browse Through More Reports Similar to the Global Cardiac Tissue Engineering Market 2025, By The Business Research Company

Implantable Cardiac Rhythm Management Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-cardiac-rhythm-management-device-global-market-report

Cardiac Safety Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-safety-services-global-market-report

Cardiac Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795